TYK Medicines' Chairman Boosts Stake; Shares Down 8%
MT Newswires Live
Yesterday
TYK Medicines (HKG:2410) said Chairman and Chief Executive Officer Wu Yusheng has recently purchased company shares on the open market and may make further purchases depending on market conditions.
The total increase in his shareholding is currently expected not to exceed HK$2 million, according to a Hong Kong bourse filing.
Wu will fund the purchases with his own funds and has undertaken to voluntarily lock up the shares acquired over the next month for six months from their respective purchase dates.
Shares of the firm were down nearly 10% in Wednesday morning trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.